Two Companies, Two BARDA Contracts, Two Approaches To Coronavirus

 
• By Brenda Sandburg

Sanofi follows Janssen in teaming up with HHS' BARDA to develop a COVID-19 vaccine; using technology platform of its Flublok vaccine, Sanofi expects to enter clinical trials in 1 to 1 ½ years.

PS2002_Corona virus vaccine_1630992484_1200.jpg
HHS is collaborating with Sanofi on coronarvirus vaccine candidate using platform in Flublok

More from Vaccines

More from Pink Sheet